Aspiriant, LLC
- SEC CIK
- 0001433541
- Latest filing
- Jul 20, 2026
SRE holding history
Sempra in every 13F filed by Aspiriant, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SRE overviewAll 13F holders of SREFull Q2 2026 holdings
- Shares (Q2 2026)
- 2,900
- Value
- $268.9K
- % of portfolio
- <0.1%
- Quarters held
- 13
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 2,900 | $268.9K | <0.1% | −2,444−45.7% | Reduced | Holders |
| Q1 2026 | 5,344 | $519.3K | <0.1% | +5,344 | New | Holders |
| Q1 2025 | 0 | $0 | 0.0% | −2,548−100.0% | Sold out | Holders |
| Q4 2024 | 2,548 | $223.5K | <0.1% | −108−4.1% | Reduced | Holders |
| Q3 2024 | 2,656 | $222.1K | <0.1% | +2,656 | New | Holders |
| Q2 2023 | 0 | $0 | 0.0% | −2,995−100.0% | Sold out | Holders |
| Q1 2023 | 2,995 | $452.7K | <0.1% | +871+41.0% | Added | Holders |
| Q4 2022 | 2,124 | $328.2K | <0.1% | +10.0% | Added | Holders |
| Q3 2022 | 2,123 | $318.0K | <0.1% | −6−0.3% | Reduced | Holders |
| Q2 2022 | 2,129 | $320.0K | <0.1% | −412−16.2% | Reduced | Holders |
| Q1 2022 | 2,541 | $427.0K | <0.1% | −264−9.4% | Reduced | Holders |
| Q4 2021 | 2,805 | $371.0K | <0.1% | +735+35.5% | Added | Holders |
| Q3 2021 | 2,070 | $262.0K | <0.1% | +17+0.8% | Added | Holders |
| Q2 2021 | 2,053 | $272.0K | <0.1% | −173−7.8% | Reduced | Holders |
| Q1 2021 | 2,226 | $295.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.